Trial Profile
The safety and efficacy of etelcalcetide for the treatment of secondary hyperparathyroidism compared with cinacalcet
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 May 2017
Price :
$35
*
At a glance
- Drugs Etelcalcetide (Primary) ; Cinacalcet
- Indications Secondary hyperparathyroidism
- Focus Adverse reactions
- 16 May 2017 New trial record